Comparative Effectiveness of Anti-TNF Agents for Crohn’s Disease in a Tertiary Referral IBD Practice

被引:0
|
作者
Seema A. Patil
Ankur Rustgi
Patricia Langenberg
Raymond K. Cross
机构
[1] University of Maryland School of Medicine,Division of Gastroenterology and Hepatology, Department of Medicine
[2] University of Maryland,Department of Epidemiology and Public Health, School of Medicine
[3] Veterans Affairs,undefined
[4] Maryland Heath Care System,undefined
来源
关键词
Crohn’s disease; Anti-TNF therapy; Infliximab; Adalimumab; Certolizumab pegol;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:209 / 215
页数:6
相关论文
共 50 条
  • [21] Sequencing of Anti-TNF Agents and Vedolizumab in the Treatment of Crohn's Disease (CD)
    Huang, Zhongwen
    Ba, Yi
    Wang, Song
    Kamble, Pravin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S433 - S433
  • [22] Methotrexate use in combination with anti-TNFα agents in IBD: A tertiary centre experience
    Waddingham, W.
    Nwaogu, A.
    Michael, E.
    Whitley, L.
    Parker, H.
    Kettle, R.
    Parisi, I.
    Seward, E.
    McCartney, S.
    Bloom, S.
    Vega, R.
    Rahman, F.
    Mehta, S.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S298 - S299
  • [23] Choice of Anti-TNF Agents Does Not Effect Clinical Outcomes in Patients With Crohn's Disease Evaluated at a Referral Center
    Patil, Seema
    Rustgi, Ankur
    Cross, Raymond
    GASTROENTEROLOGY, 2010, 138 (05) : S540 - S540
  • [24] TNF and anti-TNF agents in Behcet's disease
    Calamia, KT
    ARTHRITIS RESEARCH & THERAPY, 2003, 5 (Suppl 2) : S3 - S3
  • [25] Comparing the Effectiveness of Anti-TNF Agents for the Treatment of Crohn's Disease: a Bayesian Network Meta-Analysis
    Stidham, Ryan W.
    Lee, Terrence
    Higgins, Peter D.
    Deshpande, Amar R.
    Sussman, Daniel A.
    Singal, Amit G.
    Elmunzer, B. Joseph J.
    Saini, Sameer D.
    Vijan, Sandeep
    Waljee, Akbar K.
    GASTROENTEROLOGY, 2014, 146 (05) : S202 - S202
  • [26] Optimizing Immunomodulators and Anti-TNF Agents in the Therapy of Crohn Disease
    Dassopoulos, Themistocles
    Sninsky, Charles A.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2012, 41 (02) : 393 - +
  • [27] Anti-TNF and Fistulising Perianal Crohn's Disease: Use in Clinical Practice
    Bourikas, Leonidas A.
    Koutroubakis, Ioannis E.
    CURRENT DRUG TARGETS, 2010, 11 (02) : 187 - 197
  • [28] Anti-TNFα treatment efficacy in prevention of postoperative recurrence in Crohn's disease depends on previous exposure to anti-TNFα agents
    Collins, M.
    Sarter, H.
    Gower-Rousseau, C.
    Koriche, D.
    Nachury, M.
    Libier, L.
    Cortot, A.
    Zerbib, P.
    Colombel, J. -F.
    Peyrin-Biroulet, L.
    Desreumaux, P.
    de Chambrun, G. Pineton
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S316 - S316
  • [29] Anti-TNFα Treatment Efficacy in Prevention of Postoperative Recurrence in Crohn's Disease Depends on Previous Exposure to Anti-TNFα Agents
    Collins, Michael
    Sarter, Helene
    Gower-Rousseau, Corinne
    Koriche, Dine
    Nachury, Maria
    Libier, Louise
    Cortot, Antoine
    Zerbib, Philippe
    Colombel, Jean-Frederic
    Peyrin-Biroulet, Laurent
    Desreumaux, Pierre
    de Chambrun, Guillaume Pineton
    GASTROENTEROLOGY, 2015, 148 (04) : S863 - S863
  • [30] Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agent
    del Carmen R-Grau, Maria
    Chaparro, Maria
    Mesonero, Francisco
    Barreiro-de Acosta, Manuel
    Castro, Luisa
    Castro, Manuel
    Domenech, Eugeni
    Mancenido, Noemi
    Lazaro Perez-Calle, Jose
    Taxonera, Carlos
    Barrio, Jesus
    De Francisco, Ruth
    Fernandez-Salgado, Estela
    Luzon, Lara
    Merino, Olga
    Oltra, Lorena
    Saro, Cristina
    Bermejo, Fernando
    Garcia-Sanchez, Valle
    Ginard, Daniel
    Gutierrez, Ana
    Vera, Isabel
    Anton, Rosario
    Ber, Yolanda
    Calvet, Xavier
    Gisbert, Javier P.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (06) : 613 - 619